CT SB00749

Requires the Commissioner of Consumer Protection to classify xylazine as a Schedule IV controlled substance under Connecticut's controlled substance scheduling regulations

Targets xylazine due to its misuse as an adulterant mixed with opioid drugs and fentanyl

Schedule IV classification indicates substances with low potential for abuse relative to Schedule III, with accepted medical use